Keiko Ihara

420 total citations
21 papers, 131 citations indexed

About

Keiko Ihara is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Keiko Ihara has authored 21 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 6 papers in Pathology and Forensic Medicine and 4 papers in Neurology. Recurrent topics in Keiko Ihara's work include Migraine and Headache Studies (14 papers), Trigeminal Neuralgia and Treatments (5 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Keiko Ihara is often cited by papers focused on Migraine and Headache Studies (14 papers), Trigeminal Neuralgia and Treatments (5 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Keiko Ihara collaborates with scholars based in Japan, United States and Italy. Keiko Ihara's co-authors include Tsubasa Takizawa, Nobuyuki Takahashi, Jin Nakahara, Naoki Miyazaki, Ryo Takemura, Satoko Hori, Kei Ishizuchi, Igor Petrušić, Sho Yagishita and Paolo Martelletti and has published in prestigious journals such as Nature Communications, Journal of the Neurological Sciences and Cephalalgia.

In The Last Decade

Keiko Ihara

16 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiko Ihara Japan 7 98 56 19 16 15 21 131
Bronwyn Jenkins Australia 8 124 1.3× 65 1.2× 32 1.7× 27 1.7× 9 0.6× 16 198
Carmelina Maria Costa Italy 7 104 1.1× 69 1.2× 22 1.2× 11 0.7× 7 0.5× 10 148
Gloria Vaghi Italy 9 154 1.6× 75 1.3× 36 1.9× 13 0.8× 10 0.7× 26 215
Pietro Querzani Italy 5 82 0.8× 57 1.0× 11 0.6× 11 0.7× 9 0.6× 8 110
Giulia Chiarle Italy 8 208 2.1× 91 1.6× 46 2.4× 15 0.9× 5 0.3× 11 289
Yen‐Feng Wang Taiwan 8 141 1.4× 43 0.8× 40 2.1× 13 0.8× 21 1.4× 32 228
Andreas Husøy Norway 9 145 1.5× 55 1.0× 29 1.5× 17 1.1× 11 0.7× 25 170
Daisuke Danno Japan 10 152 1.6× 70 1.3× 31 1.6× 11 0.7× 6 0.4× 34 205
Silvia Sinigaglia Italy 7 213 2.2× 81 1.4× 69 3.6× 16 1.0× 5 0.3× 8 277
Judith A. Pijpers Netherlands 6 153 1.6× 124 2.2× 50 2.6× 39 2.4× 11 0.7× 10 219

Countries citing papers authored by Keiko Ihara

Since Specialization
Citations

This map shows the geographic impact of Keiko Ihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Ihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Ihara more than expected).

Fields of papers citing papers by Keiko Ihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Ihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Ihara. The network helps show where Keiko Ihara may publish in the future.

Co-authorship network of co-authors of Keiko Ihara

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Ihara. A scholar is included among the top collaborators of Keiko Ihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Ihara. Keiko Ihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ihara, Keiko, Ryo Takemura, Kei Ishizuchi, et al.. (2025). Efficacy and Safety of Switching between Anti-CGRP Monoclonal Antibodies: A Detailed Monthly and Long-term Follow-up Study and Literature Review. Internal Medicine. 64(14). 2114–2123.
3.
4.
Unekawa, Miyuki, et al.. (2025). Effect of lacosamide on cortical spreading depolarization in mice. The Journal of Headache and Pain. 26(1). 163–163.
5.
Takizawa, Tsubasa, Keiko Ihara, Miyuki Unekawa, et al.. (2024). Effects of passive smoking on cortical spreading depolarization in male and female mice. The Journal of Headache and Pain. 25(1). 162–162. 1 indexed citations
6.
Ihara, Keiko, Ahmed Dahshan, Wonwoo Lee, et al.. (2024). Are we closer to achieving precision medicine for migraine treatment? A narrative review. Cephalalgia. 44(9). 2225326574–2225326574. 3 indexed citations
7.
Takizawa, Tsubasa, Keiko Ihara, Ryo Takemura, et al.. (2024). CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society. The Journal of Headache and Pain. 25(1). 39–39. 8 indexed citations
8.
Waliszewska‐Prosół, Marta, Danilo Antonio Montisano, Keiko Ihara, et al.. (2024). The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study. The Journal of Headache and Pain. 25(1). 27–27. 29 indexed citations
9.
Ihara, Keiko, Nobuyuki Takahashi, Kei Ishizuchi, et al.. (2024). Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in Japan. Internal Medicine. 64(6). 825–831. 1 indexed citations
10.
Ihara, Keiko, et al.. (2024). A reinforcement learning model with choice traces for a progressive ratio schedule. Frontiers in Behavioral Neuroscience. 17. 1302842–1302842. 2 indexed citations
11.
Ihara, Keiko, et al.. (2024). Application of Artificial Intelligence in the Headache Field. Current Pain and Headache Reports. 28(10). 1049–1057. 5 indexed citations
12.
Ihara, Keiko, Nobuyuki Takahashi, Naoki Miyazaki, et al.. (2023). Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study. The Journal of Headache and Pain. 24(1). 23–23. 34 indexed citations
13.
Ihara, Keiko, Nobuyuki Takahashi, Naoki Miyazaki, et al.. (2023). Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosing. Journal of the Neurological Sciences. 453. 120811–120811. 10 indexed citations
14.
Shikano, Yu, Jun Ogasawara, Kenichi Makino, et al.. (2023). Mesolimbic dopamine release precedes actively sought aversive stimuli in mice. Nature Communications. 14(1). 2433–2433. 15 indexed citations
15.
Ihara, Keiko, Nobuyuki Takahashi, Naoki Miyazaki, et al.. (2023). Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study. BMC Neurology. 23(1). 404–404. 6 indexed citations
16.
Takizawa, Tsubasa, Keiko Ihara, Shunsuke Uno, et al.. (2023). Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review. Expert Opinion on Drug Metabolism & Toxicology. 19(12). 951–967. 3 indexed citations
17.
Ihara, Keiko, et al.. (2022). A prediction model of qi stagnation: A prospective observational study referring to two existing models. Computers in Biology and Medicine. 146. 105619–105619. 4 indexed citations
18.
Sato, Seiichi, et al.. (1990). [Congenital atresia of the left main coronary artery ostium--a case suffering from ventricular tachycardia].. PubMed. 38(9). 1467–74. 8 indexed citations
19.
Yoshida, Hidenori, Keiko Ihara, Hiroshi Yamanari, et al.. (1989). Sequential changes in blood pressure and electrocardiographic findings over seventeen years in three different regions in okayama prefecture.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 26(4). 375–386. 1 indexed citations
20.
Nakano, S, Shin Kitamura, Kazumitsu Onishi, et al.. (1981). [Hemodynamic response to exercise in the patients with extreme pulmonary hypertension accompanied by mitral stenosis after open mitral commissurotomy (author's transl)].. PubMed. 29(3). 335–41.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bronwyn Jenkins Breakdown of academic impact, for papers by Carmelina Maria Costa Breakdown of academic impact, for papers by Gloria Vaghi Breakdown of academic impact, for papers by Pietro Querzani Breakdown of academic impact, for papers by Giulia Chiarle Breakdown of academic impact, for papers by Yen‐Feng Wang Breakdown of academic impact, for papers by Andreas Husøy Breakdown of academic impact, for papers by Daisuke Danno Breakdown of academic impact, for papers by Silvia Sinigaglia Breakdown of academic impact, for papers by Judith A. Pijpers
Rankless by CCL
2026